Risk factors and prediction of preeclampsia

Acta Clinica Belgica

Volumn 65, Issue 1, 2010, Pages 1-12

  Jacquemyn, Yves ^a   Zemtsova, O ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Fetus; Placenta; Preeclampsia; Pregnancy

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; PLACENTA PROTEIN;

ARTERIAL PRESSURE; BIOCHEMISTRY; DOPPLER ECHOCARDIOGRAPHY; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; MATERNAL SERUM; PREDICTION; PREECLAMPSIA; PROTEIN URINE LEVEL; REVIEW; RISK FACTOR; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 77949506181     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2010.001     Document Type: Review

References (93)

1. Jacquemyn Y., Osmanovic F., Martens G. Preeclampsia and birthweight by gestational age in singleton pregnancies in Flanders, Belgium : a prospective study. Clin Exp Obstet Gynecol. 2006; 33: 96-98.
2. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 565.
3. Shevell T, Malone FD, Vidaver J et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol. 2005 Nov;106(5 Pt 1):1039-45.
4. Jacquemyn Y., Martens G., Esmans A., Buytaert Ph. Enkele aspecten van perinatale epidemiologie bij migranten in Vlaanderen. Tijdschrift voor Geneeskunde, : 2000 ; 56, 822-829
5. Jacquemyn Y, Gys SV, Verdonck P. Fetal biometry in different ethnic groups. Early Hum Dev 2000; 57: 1-13
6. Allen VM, Wilson RD, Cheung A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC); Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC). Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006; 28:220-50.
7. Woldringh GH, Frunt MH, Kremer JA, Spaanderman ME. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Hum Reprod. 2006; 21:2948-54.
8. Howarth C, Gazis A, James D. Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med. 2007; 24:1229-34.
9. Qiu C, Williams MA, Calderon-Margalit R, Cripe SM, Sorensen TK. Preeclampsia Risk in Relation to Maternal Mood and Anxiety Disorders Diagnosed Before or During Early Pregnancy. Am J Hypertens 2009; 22: 397-402
10. Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández- Díaz S. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry. 2009 166: 320-8.
11. Hiltunen LM, Laivuori H, Rautanen A et al. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: A population-based nested case-control study. Thromb Res. 2009; 124: 167-173
12. Clark P, Wu O. ABO(H) blood groups and pre-eclampsia. A systematic review and meta-analysis. Thromb Haemost. 2008;100: 469-74.
13. Trogstad L, Magnus P, Skjaerven R, Stoltenberg C. Previous abortions and risk of pre-eclampsia. Int J Epidemiol. 2008;37:1333-40.
14. Magnus P, Trogstad L, Owe KM, Olsen SF, Nystad W. Recreational physical activity and the risk of preeclampsia: a prospective cohort of Norwegian women. Am J Epidemiol. 2008; 168 952-7.
15. Qiu C, Coughlin KB, Frederick IO, Sorensen TK, Williams MA. Dietary fiber intake in early pregnancy and risk of subsequent preeclampsia. Am J Hypertens. 2008;21: 903-9.
16. Triche EW, Grosso LM, Belanger K, Darefsky AS, Benowitz NL, Bracken MB. Chocolate consumption in pregnancy and reduced likelihood of preeclampsia. Epidemiology. 2008; 19:459-64.
17. Vergnes JN. Studies suggest an association between maternal periodontal disease and pre-eclampsia. Evid Based Dent. 2008;9: 46-7.
18. Silva L.M, Coolman M., Steegers E.A. et al. Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study. J Hypertens. 2008;26:1200-8.
19. Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens. 2008;21:943-7.
20. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51:1002-9.
21. Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol. 2008;199:55-62.
22. Ness RB, Markovic N, Harger G, Day R. Barrier methods, length of preconception intercourse, and preeclampsia. Hypertens Pregnancy. 2004;230:227-35
23. Koelman CA, Coumans AB, Nijman HW, Doxiadis II, Dekker GA, Claas FH. Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J Reprod Immunol. 2000;46:155-66
24. Need JA, Bell B, Meffin E, Jones WR. Pre-eclampsia in pregnancies from donor inseminations. J Reprod Immunol. 1983 5:329-38.
25. Dekker G, Robillard PY. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol. 2003; 59:245-51.
26. Verwoerd GR, Hall DR, Grové D, Maritz JS, Odendaal HJ. Primipaternity and duration of exposure to sperm antigens as risk factors for pre-eclampsia. Int J Gynaecol Obstet. 2002; 78:121-6.
27. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ. 1998; 316:1343-7
28. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199:127-133.
29. Sanchez SE, Qiu C, Williams MA, Lam N, Sorensen TK. Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women. Am J Hypertens. 2008;21:360-4.
30. Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J. 2008 Mar;12(2):223-42.
31. Tam WH, Sahota DS, Lau TK, Li CY, Fung TY. Seasonal variation in pre-eclamptic rate and its association with the ambient temperature and humidity in early pregnancy. Gynecol Obstet Invest. 2008;66:22-6.
32. Cnossen JS, van der Post JA, Mol BW, Khan KS, Meads CA, ter Riet G. Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy. BMC Pregnancy Childbirth. 2006;19;6:29.
33. Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension. 2008;51:1027-33.
34. De Paco C, Kametas N, Rencoret G, Strobl I, Nicolaides KH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol. 2008;111:292-300.
35. Poon LC, Kametas N, Bonino S, Vercellotti E, Nicolaides KH. Urine albumin concentration and albumin-to-creatinine ratio at 11(+0) to 13(+6) weeks in the prediction of pre-eclampsia. BJOG. 2008;115:866-73.
36. Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2007 19:103-9
37. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol. 2000 Oct;96(4):559-64
38. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18:441-9.
39. Vainio M, Kujansuu E, Iso-Mustajärvi M, Mäenpää J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002; 109: 161-167
40. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2004;(1). Issue 2. Art. No.: CD004659.
41. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18:583-6.
42. Prefumo F, Fratelli N, Soares SC, Thilaganathan B. Uterine artery Doppler velocimetry at 11-14 weeks in singleton pregnancies conceived by assisted reproductive technology. Ultrasound Obstet Gynecol. 2007;29:141-5.
43. Meads CA, Cnossen JS, Meher S et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2008 Mar;12(6):iii-iv, 1-270
44. Hafner E, Metzenbauer M, Höfinger D et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol. 2006; 27:652-7.
45. Khalil AA, Cooper DJ, Harrington KF. Pulse wave analysis: a preliminary study of a novel technique for the prediction of preeclampsia. BJOG. 2009 Jan;116: 268-76
46. Phaloprakarn C, Tangjitgamol S. Impact of high maternal hemoglobin at first antenatal visit on pregnancy outcomes: a cohort study. J Perinat Med. 2008;36:115-9.
47. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008 31:493-502.
48. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005;25:949-53.
49. Hershkovitz R, de Swiet M, Kingdom J. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy. 2005;24:273-80.
50. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol. 2006;27:658-63.
51. Prefumo F, Canini S, Casagrande V, Pastorino D, Venturini PL, De Biasio P. Correlation between first-trimester uterine artery Doppler indices and maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril. 2006 86:977-80.
52. Whittle W, Chaddha V, Wyatt P, Huppertz B, Kingdom J. Ultrasound detection of placental insufficiency in women with 'unexplained' abnormal maternal serum screening results. Clin Genet. 2006;69:97-104.
53. Alkazaleh F, Chaddha V, Viero S et al. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin. Am J Obstet Gynecol. 2006;194:821-7.
54. Elsandabesee D, Srinivas M, Kodakkattil S. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome. J Obstet Gynaecol. 2006;26:115-7.
55. Barkehall-Thomas A, Wilson C, Baker L, ni Bhuinneain M, Wallace EM. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated midtrimester beta-human chorionic gonadotrophin. Acta Obstet Gynecol Scand. 2005;84:743-7.
56. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol. 2007 Feb;29(2):128-34.
57. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol. 2009 33:23-33.
58. Chafetz I, Kuhnreich I, Sammar M et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2007;197:35-42
59. Gonen R, Shahar R, Grimpel YI et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG. 2008 115:1465-72.
60. Wortelboer E.J., Koster M.P., Stoutenbeek P.C.J.,Visser G.H. Biochemical screening for preeclampsia in the first trimester. Reproductieve geneeskunde , gynaecologie en obstetrie 2009, p. 252-255; ISBN 978-90-811646-5-81
61. Spencer K, Cowans NJ, Chefetz I, Tal J, Kuhnreich I, Meiri H. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia. Prenat Diagn. 2007;27:258-63.
62. Nicolaides KH, Bindra R, Turan OM et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006; 27:13-7.
63. Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol. 2006;195:1668-73.
64. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007;109:168-80.
65. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand. 2008;87:837-42.
66. Savvidou MD, Akolekar R, Zaragoza E, Poon LC, Nicolaides KH. First trimester urinary placental growth factor and development of pre-eclampsia. BJOG. 2009;116:643-7.
67. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007;196:239-235.
68. Rana S, Karumanchi SA, Levine RJ et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007;50:137-42
69. Wathén KA, Ylikorkala O, Andersson S, Alfthan H, Stenman UH, Vuorela P. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Acta Obstet Gynecol Scand. 2009;88:593-8.
70. Guen MA, Ertas Ie, Kilinc M, Coskun A, Ekerbicher H. Combining mid-trimester maternal plasma homocysteine with uterine artery doppler velocimetry: is it useful ? Arch Gynecol Obstet 2007; 275: 439-443
71. Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol. 2008;112:1082-90.
72. Levine RJ, Lam C, Qian C et al. CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.
73. Erez O, Romero R, Espinoza J et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008 . 21: 279-87.
74. Sibai BM. Hypertensive disorders of pregnancy: the United States perspective. Curr Opin Obstet Gynecol. 2008;20:102-6.
75. Dudding T, Heron J, Thakkinstian A et al. Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis. J Thromb Haemost. 2008;6:1869-75.
76. Purwosunu Y, Sekizawa A, Okazaki S, et al Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma. Am J Obstet Gynecol. 2009;200:386 - 393.
77. Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH. First-trimester maternal serum tumor necrosis factor receptor-1 and
78. pre-eclampsia. Ultrasound Obstet Gynecol. 2009;33:135-41. 77. Zafarmand MH, Nijdam ME, Franx A, Grobbee DE, Bots ML. The angiotensinogen gene M235T polymorphism and development of preeclampsia/eclampsia: a meta-analysis and meta-regression of observational studies. J Hypertens. 2008 Sep;26(9):1726-34.
79. Lynch AM, Murphy JR, Byers T et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol. 2008;198:385-394
80. Vatten LJ, Nilsen TI, Juul A, Jeansson S, Jenum PA, Eskild A. Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol. 2008;158:101-5.
81. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia.J Clin Endocrinol Metab. 2007;92:3517-22.
82. Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn. 2009; 29: 553 - 559
83. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW. In-flammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv. 2007;62:191-201.
84. Redman CW, Sargent IL.Latest advances in understanding preeclampsia. Science. 2005 308:1592-4
85. Lee LC, Sheu BC, Shau WY et al. Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia. Prenat Diagn. 2000
86. Stamilo M., Sehdev H.M., Mogan M.A.,Propert K., Macones G.A. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000; 182:589-94.
87. August P, Helseth G, Cook EF, Sison C. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol. 2004: 191:1666-72.
88. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol. 2005; 193:429-36.
89. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30:742-9.
90. Onwudiwe N, Yu CK, Poon LC, Spiliopoulos I, Nicolaides KH. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol 2008; 32: 877-883
91. Deis S, Rouzier R, Kayem G, Masson C, Haddad B. Development of a nomogram to predict occurrence of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2008;137:146-51.
92. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; PARIS Collaborative Group. Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet. 2007; 26;369:1791-8.
93. Hofmeyr GJ, Duley L, Atallah A.Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007; 114 :933-43.